Foa, Edna B <br/><br/>
Six-month outcomes from a randomized trial augmenting serotonin reuptake inhibitors with exposure and response prevention or risperidone in adults with obsessive-compulsive disorder.  [electronic resource] 

 -  The Journal of clinical psychiatry  Apr 2015 
 - 440-6 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1555-2101 
<br/><br/><label>Standard No.: </label>10.4088/JCP.14m09044  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Combined Modality Therapy<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Implosive Therapy<br/>Male<br/>Middle Aged<br/>Obsessive-Compulsive Disorder--diagnosis<br/>Risperidone--adverse effects<br/>Selective Serotonin Reuptake Inhibitors--adverse effects<br/>United States<br/>Young Adult